Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
Domain
mirumpharma.com
Country
United StatesIndustry
BiotechnologyEmployees
251-500
Last Funding
$68.5M
Founded
2017
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does Mirum Pharmaceuticals use?+
Mirum Pharmaceuticals uses 15 technologies including Google Analytics, Google Tag Manager, WordPress.
What industry is Mirum Pharmaceuticals in?+
Mirum Pharmaceuticals operates in the Biotechnology industry.
Where is Mirum Pharmaceuticals based?+
Mirum Pharmaceuticals is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026